REVELATION BIOSCIENCES, INC. Proceeds from Issuance of Warrants
REVELATION BIOSCIENCES, INC. (REVB) reported Proceeds from Issuance of Warrants of $6.70 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2026-02-26
- REVELATION BIOSCIENCES, INC. proceeds from issuance of warrants for fiscal 2025 was $6.70M.
- REVELATION BIOSCIENCES, INC. proceeds from issuance of warrants for fiscal 2020 was $83.45K.
| Period end | Proceeds from Issuance of Warrants 12 month |
|---|---|
| 2025-12-31 | $6.70M 10-K · filed 2026-02-26 |
| 2020-12-31 | $83.45K 10-K/A · filed 2021-06-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |